FDA Approves Therapy for Advanced Urothelial Cancer – Renal and Urology News
Padcev is the first antibody-drug conjugate approved for advanced urothelial cancer patients.
Related Articles
Node-Positive Status After UTUC Neoadjuvant Chemo Tied to Worse Recurrence, Survival
Residual nodal disease following neoadjuvant chemotherapy for upper tract urothelial carcinoma (UTUC) indicates an especially high-risk population.
Tolvaptan Treatment for ADPKD Slows Kidney Function Decline Over the Long Term
Real-world data supports tolvaptan use to slow kidney function decline in patients with autosomal dominant polycystic kidney disease (ADPKD).
Hemorrhagic Peptic Ulcer Disease Hospitalizations Up in Advanced CKD, ESKD
Patients with advanced chronic kidney disease are at increased risk of hemorrhagic peptic ulcer disease hospitalization and adverse outcomes.
Many Patients With Metastatic ccRCC Continue to Receive TKI, ICI Monotherapies
Although recommended, many patients with metastatic clear cell RCC still don’t receive immune checkpoint inhibitor-based combinations as first-line treatment.
Radical Prostatectomy More Complex With Obesity but Oncologic Outcomes Appear Similar
Obesity in itself is not a contraindication for radical prostatectomy, but it remains a risk factor for poor overall survival.
Canagliflozin May Improve Iron Utilization in Diabetic Nephropathy
Study findings identify a clear role of SGLT2 inhibitors in iron metabolism.
Intravenous Magnesium May Cut Risk for Cisplatin-Induced Acute Kidney Injury
There are currently no proven therapies that reduce cisplatin-induced acute kidney injury (AKI) in patients with cancer.
New Insight into Genetic Drivers of Prostate Cancer
Study results underscore the importance of including multi-ancestry cohorts in prostate cancer research.
Radical Prostatectomy More Complex With Obesity but Oncologic Outcomes Appear Similar
Obesity in itself is not a contraindication for radical prostatectomy, but it remains a risk factor for poor overall survival.
Hemorrhagic Peptic Ulcer Disease Hospitalizations Up in Advanced CKD, ESKD
Patients with advanced chronic kidney disease are at increased risk of hemorrhagic peptic ulcer disease hospitalization and adverse outcomes.